Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2050-6511
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis ; volume:22 ; number:1 ; day:1 ; month:10 ; year:2021 ; pages:1-9 ; date:12.2021
BMC pharmacology & toxicology ; 22, Heft 1 (1.10.2021), 1-9, 12.2021
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Akbari, Rasoul
Behdarvand, Tahereh
Afarin, Reza
Yaghooti, Hamid
Jalali, Mohammad Taha
Mohammadtaghvaei, Narges
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40360-021-00524-8
- URN
-
urn:nbn:de:101:1-2021121909443525471795
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akbari, Rasoul
- Behdarvand, Tahereh
- Afarin, Reza
- Yaghooti, Hamid
- Jalali, Mohammad Taha
- Mohammadtaghvaei, Narges
- SpringerLink (Online service)
Ähnliche Objekte (12)
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
FAT score: an Indian insight to a novel diagnostic score to differentiate non-alcoholic steatohepatitis (NASH) from simple steatosis
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
FAT score: an Indian insight to a novel diagnostic score to differentiate non-alcoholic steatohepatitis (NASH) from simple steatosis
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
The protective effects of Ninjin’yoeito against liver steatosis/fibrosis in a non-alcoholic steatohepatitis model mouse
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
FAT score: an Indian insight to a novel diagnostic score to differentiate non-alcoholic steatohepatitis (NASH) from simple steatosis
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis